Literature DB >> 12829425

Exposure to cannabinoids in the development of endogenous cannabinoid system.

José A Ramos1, Rosario De Miguel, Maribel Cebeira, Mariluz Hernandez, Javier Fernández-Ruiz.   

Abstract

New data strengthen the idea of a prominent role for endocannabinoids in the modulation of a wide variety of neurobiological functions. Among these, two functions, control of movement and antinociception, have attracted the maximal interest because of the possibility that cannabinoids and related compounds might be used with a therapeutic purpose. However, the functions of endocannabinoids in the brain, and also in the periphery, are large and involve, not only the adulthood, but also the period of prenatal and postnatal development, when endocannabinoids have been reported to be significantly present and to play a role in processes of brain development as neuronal proliferation and migration, axonal elongation, synaptogenesis and/or myelinogenesis. The present review article will summarize the different studies carried out on this topic and will suggest future lines of research to clarify the role of endocannabinoids and their receptors in the development.

Entities:  

Year:  2002        PMID: 12829425     DOI: 10.1080/1029842021000010893

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  58 in total

1.  Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry.

Authors:  P Mailleux; J J Vanderhaeghen
Journal:  Neuroscience       Date:  1992       Impact factor: 3.590

2.  Control of membrane phosphatidylcholine biosynthesis by diacylglycerol levels in neuronal cells undergoing neurite outgrowth.

Authors:  W Araki; R J Wurtman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat.

Authors:  N E Buckley; S Hansson; G Harta; E Mezey
Journal:  Neuroscience       Date:  1998-02       Impact factor: 3.590

4.  Ontogeny of the metencephalic, mesencephalic and diencephalic content of catecholamines as measured by high performance liquid chromatography with electrochemical detection.

Authors:  N Parés-Herbuté; L Tapia-Arancibia; H Astier
Journal:  Int J Dev Neurosci       Date:  1989       Impact factor: 2.457

5.  Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain.

Authors:  A Bonnin; R de Miguel; J G Castro; J A Ramos; J J Fernandez-Ruiz
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

6.  Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period.

Authors:  F Berrendero; N Sepe; J A Ramos; V Di Marzo; J J Fernández-Ruiz
Journal:  Synapse       Date:  1999-09-01       Impact factor: 2.562

7.  Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.

Authors:  S Sagan; L Venance; Y Torrens; J Cordier; J Glowinski; C Giaume
Journal:  Eur J Neurosci       Date:  1999-02       Impact factor: 3.386

8.  Maternal exposure to the synthetic cannabinoid HU-210: effects on the endocrine and immune systems of the adult male offspring.

Authors:  I del Arco; R Muñoz; F Rodríguez De Fonseca; L Escudero; J L Martín-Calderón; M Navarro; M A Villanúa
Journal:  Neuroimmunomodulation       Date:  2000       Impact factor: 2.492

9.  Identification of cannabinoid receptors in cultures of rat cerebellar granule cells.

Authors:  M A Pacheco; S J Ward; S R Childers
Journal:  Brain Res       Date:  1993-02-12       Impact factor: 3.252

Review 10.  'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance.

Authors:  V Di Marzo
Journal:  Biochim Biophys Acta       Date:  1998-06-15
View more
  4 in total

1.  Neurodevelopmental liabilities of substance abuse.

Authors:  Tomas Palomo; Trevor Archer; Richard J Beninger; Richard M Kostrzewa
Journal:  Neurotox Res       Date:  2002-06       Impact factor: 3.911

Review 2.  Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerability.

Authors:  Tomas Palomo; R M Kostrzewa; R J Beninger; T Archer
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

Review 3.  Cannabinoids and gene expression during brain development.

Authors:  Javier Fernández-Ruiz; María Gómez; Mariluz Hernández; Rosario de Miguel; José A Ramos
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

4.  Effects of cannabinoids on the development of chick embryos in ovo.

Authors:  Sofia B Gustafsson; Stig O P Jacobsson
Journal:  Sci Rep       Date:  2019-09-17       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.